Bowen Acquisition Corp has entered into a business combination agreement with Shenzhen Qianzhi BioTechnology Co. Ltd. and will issue 500,000 shares at $10 each for $5 million in a private investment in public equity (PIPE) deal, contingent on the business combination's completion.